Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chemotherapy-induced Anemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 8 of 0 results

Post-approval studies (Phase 4)Looking for participantsNCT05874401
What this trial is testing

Trilaciclib vs Placebo in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC) Receiving Topotecan

Who this might be right for
Extensive-stage Small-cell Lung Cancer
Pharmacosmos A/S 302
Testing effectiveness (Phase 2)UnknownNCT02145923
What this trial is testing

Effectiveness and Safety of MMSCs for Enhancing Hematopoietic Recovery and Prophylaxis of Neutropenic Enterocolitis

Who this might be right for
Neutropenic EnterocolitisMyeloablative Chemotherapy Induced Bone Marrow Aplasia
Burnasyan Federal Medical Biophysical Center 16
Testing effectiveness (Phase 2)Study completedNCT00111462
What this trial is testing

Evaluating Treatment of Anemia in Subjects With Non-Myeloid MalignanciesReceiving Multicycle Chemotherapy

Who this might be right for
AnemiaNon-Myeloid MalignanciesCancer
Amgen
Testing effectiveness (Phase 2)Ended earlyNCT01284348
What this trial is testing

To Determine Safe and Effective Dose of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Participants With Advanced Non-small Cell Lung Cancer

Who this might be right for
AnemiaCarcinoma, Non-Small-Cell LungCarcinoma, Small-Cell Lung+3 more
Merck Sharp & Dohme LLC 26
Post-approval studies (Phase 4)Study completedNCT00315484
What this trial is testing

Hematologic Response of Epoetin Alfa (PROCRIT) Versus Darbepoetin Alfa (ARANESP) in Chemotherapy Induced Anemia

Who this might be right for
AnemiaChemotherapy
Ortho Biotech Products, L.P. 358
Large-scale testing (Phase 3)UnknownNCT00002926
What this trial is testing

Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia

Who this might be right for
LeukemiaMyelodysplastic Syndromes
European Organisation for Research and Treatment of Cancer - EORTC 80
Testing effectiveness (Phase 2)Study completedNCT00401544
What this trial is testing

Darbepoetin Alfa With or Without Intravenous (IV) Iron

Who this might be right for
AnemiaNon-Myeloid Malignancies
Amgen 243
Testing effectiveness (Phase 2)Study completedNCT00239239
What this trial is testing

Fractionated Dosing Study: Study to Evaluate Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies

Who this might be right for
Non-Myeloid MalignanciesAnemiaCancer
Amgen 44